ResMed Inc.
ResMed Appoints Experienced Healthcare Executive and CFO to Board
Summary
ResMed Inc. appointed Christopher DelOrefice to its board of directors. DelOrefice, with over 30 years of experience in strategic and operational finance, notably as CFO of Becton Dickinson and Company, will contribute his expertise to ResMed's audit committee. His appointment is effective immediately and he will stand for re-election at the 2024 annual meeting. ResMed will provide standard indemnification and compensation as per its customary practice.
Profitelligence Alerts
Get alerts for RMD
Be first to know when ResMed Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About ResMed Inc.
ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producing advanced equipment for sleep apnea therapy, chronic obstructive pulmonary disease (COPD), and various respiratory conditions. The company's offerings include a range of cutting-edge products like continuous positive airway pressure (CPAP) devices, bilevel systems, and ventilators, designed to enhance patient comfort and compliance. ResMed is also at the forefront of integrating cloud-connected devices to support improved patient monitoring and telemedicine services. The healthcare industry, particularly the medical device sector, benefits significantly from ResMed's contributions, as the company aims to address the growing needs associated with sleep and respiratory conditions. By focusing on both personal and overarching health care solutions, ResMed plays a crucial role in enhancing patient quality of life, thereby solidifying its position as a key player in the global health and respiratory care markets.
Official SEC Documents
Advertisement